Articles

Canadian mining company Gabriel Resources is using an investor-state lawsuit to push through its illegal toxic goldmine in the historical Romanian village of Roşia Montană. The claim foreshadows the multi-billion $ claims which could hit EU member states if the EU-Canada trade deal CETA comes into force.

Together with 37 organisations from across Europe, CEO launched the #StopGlyphosate European Citizens Initiative (ECI) this morning.

The EU is negotiating a number of highly controversial free trade agreements, which would give more powers to corporations. Our new report shows how regulatory cooperation in CETA and TTIP is a gift for Big Business that keeps on giving.

Last year, the EU’s trade secrets directive was enacted, but the way it defines these secrets is so broad that it will likely hinder public scrutiny of corporations in Europe. Our new report highlights what legislators and civil society organisations need to watch out for when implementing the directive.

Dozens of farmers groups and civil society organisations from across Europe have signed the Manifesto "Keep the farm TTIP- and CETA-free".

Trade unions and environmental organisations are calling on the European Parliament's environmental committee to reject the controversial EU-Canada trade deal CETA, which could undermine EU environmental and public health standards.

CEO joined forces with nine other civil society organisations working for equality, non-discrimination, transparent decision-making and strong ethics rules: in an open letter to the European Parliament we urge MEPs to oppose Oettinger’s appointment as the Comission’s head of human resources.

After nine months of hearings, the draft report of the EU Parliament’s inquiry into the Dieselgate scandal has it black on white: the European Commission and EU member states had known since 2004-05 that diesel cars’ nitrogen oxide emissions were far above legal limits – yet neither took action.

Our new report shows how industry lobbies present employee protection against work-related cancers as an 'unnecessary' burden on companies, and explains which tactics have been used to weaken and delay the European Union's revision of the Carcinogens and Mutagens Directive.